Navigation Links
Origen publishes in Nature a robust and versatile method for creating transgenic chickens

Origen Therapeutics announced today that it has succeeded in developing a robust and versatile technology for genetically modifying chickens that, for the first time, puts avian transgenics on a par with transgenic mice. The company made the announcement in conjunction with the publication of an article this week by Origen scientists and a collaborator from the University of California, Davis on its transgenic technology in the journal Nature.

Using the new technology, Origen can, in principle, make any genetic modification desired to the chicken genome, including the insertion of genetic elements for the production of human therapeutics and the modification of the chicken immune system to produce novel human sequence polyclonal antibodies. Moreover, the new technology opens up the possibility of producing chickens with enhanced agronomic traits, including resistance to avian flu.

"This research breakthrough came when we turned our attention to primordial germ cells, the precursor cells to sperm and eggs," said Marie-Cecile van de Lavoir, senior scientist at Origen. "These cells ?which we are the first to successfully culture without changing their commitment -- proved to be the key to introducing genetic elements into the chicken genome. As a result, we can now take transgene designs that work well in model systems and breed flocks of birds depositing therapeutic proteins in their eggs. The use of primordial germ cells, the ease of producing small or large flocks of chickens, and the existing infrastructure for rearing chickens and processing eggs means that therapeutic proteins can now be produced efficiently and economically in the eggs of chickens."

Origen scientists first demonstrated the potential for the production of human protein therapeutics in chicken eggs in August 2005, when company scientists published in Nature Biotechnology the production of human sequence monoclonal antibodies having greatly enhanced cancer killing activity co
'"/>

Source:jkureczka@comcast.net


Page: 1 2 3

Related biology news :

1. PLoS Medicine publishes first trial of effect of male circumcision on HIV infection
2. DOE publishes research roadmap for developing cleaner fuels
3. Nature provides inspiration for important new adhesive
4. First production of human monoclonal antibodies in chicken eggs published in Nature Biotechnology
5. Rewind, please: Nature paper shows that cell division is reversible
6. Natures process for nitrogen fixation caught in action
7. Towards precise classification of cancers based on robust gene functional expression profiles
8. Spleen may be source of versatile stem cells
9. Anemone genes reveal versatile building blocks for body plans
10. Engineer ramps up protein production, develops versatile viral spheres
11. Color-blind method opens new doors in DNA sequencing
Post Your Comments:
(Date:10/1/2014)... Case Western Reserve University researchers hope to take a ... for an aggressive form of breast cancer in leafy ... about administering the vaccine either by eating the salad ... Nicole Steinmetz, assistant professor of biomedical engineering at Case ... project. , The Susan G. Komen breast cancer organization ...
(Date:9/30/2014)... burning is published today in the first authoritative scientific ... tensions on both sides of the grouse moor management ... on the Ecohydrology of River basins) project has shown ... to support red grouse populations for gun sports, has ... physical properties, river water chemistry and river ecology. , ...
(Date:9/30/2014)... 2014--Sea monkeys have captured the popular attention of both ... life cycle -- sold as dehydrated eggs, these tiny ... more than a tank of salt water. , ... other zooplankton, brine shrimp vertically migrate in large groups ... the surface at night and retreating deeper during the ...
Breaking Biology News(10 mins):Scientists wield plant viruses against deadly human disease 2Scientists wield plant viruses against deadly human disease 3Grouse moor burning causes widespread environmental changes 2Laser-guided sea monkeys show how zooplankton migrations may affect global ocean currents 2
... SAN FRANCISCO -- The northernmost mummified forest ever found in ... global cooling. Researchers believe the trees -- buried by ... ago -- will help them predict how today,s Arctic will ... more mummified forests could emerge across North America as Arctic ...
... Two scientists at Scripps Institution of Oceanography at UC ... mysterious flashes of dazzling bioluminescent light produced by a ... of Scripps Oceanography (Wilson is now at the Australian ... a small marine snail typically found in tight clusters ...
... the little things that count, and that certainly holds ... enough to allow ions or molecules of a certain size ... nanochannels that mimic the capabilities of transmembrane proteins are highly ... been difficult to make individual artificial channels of this size ...
Cached Biology News:Ancient forest emerges mummified from the Arctic 2Ancient forest emerges mummified from the Arctic 3Scripps scientists see the light in bizarre bioluminescent snail 2Tiny channels carry big information 2Tiny channels carry big information 3
(Date:10/2/2014)... 2014  CSSi ( www.CSSiEnroll.com ), the leader ... industry, is pleased to announce its participation in ... October.  President Chris Trizna will be ... Clinical Trials New England conference sponsored by Arena ... annual Site Solutions Summit sponsored by the Society ...
(Date:10/2/2014)... and BRIDGEWATER, N.J. , ... , a leader in synthetic biology, and ... drug manufacturer by volume in the U.S., today ... Collaboration (ECC) for a target active pharmaceutical ingredient ... goal of the collaboration is to develop a ...
(Date:10/1/2014)... What: , Cambridge Semantics, the leading provider ... technology, today announced its participation in the 2014 Big ... Data solutions provide semantic linkage and meaning to Big ... and manage diverse data. Ben Szekely, vice president and ... a “life sciences data lake” and an approach for ...
(Date:10/1/2014)... 1, 2014  Discovery Laboratories, Inc. (Nasdaq: DSCO) ... a Phase II Small Business Innovation Research Grant ... the National Institute of Allergy and Infectious Diseases ... to support the development of the Company,s aerosolized ... to mitigate acute and chronic/late-phase radiation-induced lung injury. ...
Breaking Biology Technology:Patient Recruitment Expert CSSi to be Featured at Upcoming Industry Events 2Patient Recruitment Expert CSSi to be Featured at Upcoming Industry Events 3Intrexon and Amneal Expand Relationship with Second Product Collaboration 2Intrexon and Amneal Expand Relationship with Second Product Collaboration 3Cambridge Semantics to Present ‘A Useful Approach to Big Data’ at 2014 Big Data Leaders Forum 2Discovery Labs Receives SBIR Grant Valued up to $3.0 Million to Support Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives SBIR Grant Valued up to $3.0 Million to Support Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... , , , ... (Nasdaq: NBIX ) announced today that the Company will report ... Wednesday, July 29, 2009. Neurocrine will then host a ... a Company update Thursday morning, July 30, 2009 at 8:30 a.m. Eastern ...
... ASHLAND, Mass., July 23 MatTek Corp., today announced ... EpiDerm(TM) SIT non-animal alternative test method for determining the human ... , , This 20 minute ... (JoVE). Titled, "An In Vitro Skin Irritation Test (SIT) ...
... , , , ... to Severe Post-Operative Pain , , ... (Pink Sheets: QRXPY; ASX: QRX) announced today the initiation of a ... of MoxDuo(TM) IV (intravenous morphine and oxycodone) versus IV morphine alone ...
Cached Biology Technology:Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2009 Financial Results 2Video of EpiDerm Skin Irritation Test (SIT) Method Now Available 2QRxPharma Initiates Comparative Phase 2 Proof-of-Concept Study for MoxDuo(TM) IV Pain Therapy 2QRxPharma Initiates Comparative Phase 2 Proof-of-Concept Study for MoxDuo(TM) IV Pain Therapy 3
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Request Info...
Biology Products: